Aptorum Group plans 1-for-10 reverse stock split ahead of DiamiR merger
APM•Reverse split and merger details
Aptorum Group will execute a 1-for-10 reverse share split ahead of its merger with DiamiR Biosciences, expected to close around July 20, 2026.
Post-split trading is expected to begin July 20 under Niki BioSolutions on Nasdaq with the new ticker NIKI.
Outstanding Class A shares are expected to fall to about 634,682 from about 6,346,823; Class B to about 179,693 from about 1,796,934.
The reverse split targets a higher per-share price to support compliance with Nasdaq’s minimum bid requirement.
